Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R21 Clinical Trial Optional)

The summary for the Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R21 Clinical Trial Optional) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R21 Clinical Trial Optional): The purpose of this funding opportunity announcement (FOA) is to (1) promote preclinical, translational, clinical and epidemiological research in pain medications use in children or in pregnant women to fill knowledge gaps in the safe use of the pain medications in these special populations; and (2) develop effective instruments or approaches to assess and evaluate maternal and child outcomes of pain medication treatment.
Federal Grant Title: Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R21 Clinical Trial Optional)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Health Income Security and Social Services
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-18-043
Type of Funding: Grant
CFDA Numbers: 93.865
CFDA Descriptions: Information not provided
Current Application Deadline: January 7th, 2020
Original Application Deadline: January 7th, 2020
Posted Date: November 3rd, 2017
Creation Date: November 3rd, 2017
Archive Date: February 12th, 2020
Total Program Funding:
Maximum Federal Grant Award: $200,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Last Updated: November 3rd, 2017
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/pa-files/PA-18-043.html
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
Development of Novel Nonsteroidal Contraceptive Methods (R61/R33 - Clinical Trial Not Allo...
The Role of Epitranscriptomics in Development and Disease (R21 - Clinical Trial Not Allowe...
Research Infrastructure for Centers Conducting Population Dynamics Science FY 2018 (P2C - ...
Patient Safety in the Context of Perinatal, Neonatal, and Pediatric Care (R03 - Clinical T...
Patient Safety in the Context of Perinatal, Neonatal, and Pediatric Care (R01 - Clinical T...
Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Precli...
Phase II Small Business Innovation Research Renewal Awards for Device Assessment or Precli...
Reproductive Genetics and Epigenetics
More Grants from the National Institutes of Health
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
Development of Novel Nonsteroidal Contraceptive Methods (R61/R33 - Clinical Trial Not Allo...
The Role of Epitranscriptomics in Development and Disease (R01 - Clinical Trial Not Allowe...
The Role of Epitranscriptomics in Development and Disease (R21 - Clinical Trial Not Allowe...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2018 FederalGrants.com